Category: Business

Nabriva Therapeutics Gets FDA Approval for New Bacterial Pneumonia Drug

Drug-resistant bacteria is quickly becoming the scourge of this generation, an unfortunate development that could become quite a dangerous epidemic.  As such, medical scientists continue to work on new treatments that will be effective as this problem grows.  Fortunately, it appears we are already making some headway in this field.  At the

Disney Shares Dip on Earnings Miss Ahead of Streaming Launch

In a surprising announcement, Disney reported third-quarter results fell short of expectations, mostly on the outcome of rising costs for the entertainment conglomerate.  It seems these mounting costs are likely related to the company’s new streaming platform, Disney+, which is slated for launch at some point this year.  Specifically, Disney shares

Compass Raises $370 Million in Funding, Valuation Now $6.4 Billion

The high-tech real estate brokerage firm Compass has acquired even more cash, which will definitely help the innovative company to continue building out its technological platform and grow its engineering hubs on both US seaboards.  Early this week, to close out the month of July, Compass announced yet another impressive round

Strong Earnings and Higher Dividend Boosts Delta’s Second Quarter

To close out the week, Delta Airlines reported a record-setting second quarter that also beat Wall Street estimates, as earnings were boosted by stronger demand with the summer travel season now in full-swing. Accordingly, the Atlanta-based international airline reported an adjusted quarterly earnings of $2.35 per share on adjusted revenue of

Bristol-Myers Still Waiting For FTC Approval of Celgene Takeover

Shares of Bristol-Myers Squibb took a big dip to start the week after the group announced the US Federal Trade Commission (FTC) is still examining their proposed $74 billion acquisition of cancer specialist Celgene Corporation.  Offering to sell the company’s psoriasis business to move the deal forward, the FTC’s hesitancy seemed